Stanford IM residency program director, Professor of Medicine, Cardiologist, Specialist in Amyloidosis, Sarcoidosis, Cardio-Oncology, and Advanced heart failure
Jun 24 • 14 tweets • 2 min read
🚨🚨🚨 MAJOR news in the #amyloidosis world this morning with positive topline results of #HELIOS-B. #Vutrisiran met all primary & secondary endpoints. Let's break down what we know... #StanfordAmyloidCenter (1/13)
There were 2 primary endpoints -- composite of all-cause mortality & recurrent CV events in the whole population (n=654) and in the tafamidis-naive population (n=395). Both were positive! 🍾Overall pop = HR 0.718 (p=0.0118), tafamidis-naive = HR 0.672 (p=0.0162). (2/13)
Dec 19, 2020 • 10 tweets • 3 min read
1/ Thoughts/reflections on the events of the last 24 hours with the vaccine rollout at Stanford... One of the most upsetting 24 hours I have ever experienced.
2/ The rollout was an absolute mess. Pledges that were made were not followed through on. Housestaff were rightly upset to (for all practical purposes) be completely left out of the first wave. They are our very definition of frontline physicians.